Hem › Juvenil myelomonocyt leukemi › Missouri
Kliniska studier för Juvenil myelomonocyt leukemi i Missouri
3 studier för Juvenil myelomonocyt leukemi söker deltagare vid platser i Missouri.
Officiell studietext (engelska)
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
- Children's Mercy Hospital, Kansas City
RekryterarFas 1/2
1 Month – 21 Years · Alla kön · Uppdaterad 4 sep. 2026 · NCT05849662A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
- Washington University School of Medicine, St Louis
RekryterarFas 1
Ålder 1 till 18 · Alla kön · Uppdaterad 25 aug. 2026 · NCT06247787The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- University of Missouri Children's Hospital, Columbia
- Children's Mercy Hospitals and Clinics, Kansas City
- Cardinal Glennon Children's Medical Center, St Louis
- och 2 fler
RekryterarFas 1/2
Upp till ålder 22 · Alla kön · Uppdaterad 25 aug. 2026 · NCT04726241Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.